Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and neuropathological hallmarks such as amyloid plaques and neurofibrillary tangles. Environmental factors, including aluminum chloride (AlCl₃) exposure, have been implicated in neurotoxicity and AD pathogenesis. This study evaluated the combined therapeutic effects of methylphenidate (MPH) and melatonin in a mice model of AlCl₃-induced neurotoxicity. Male BALB/c mice were administered AlCl₃ (300 mg/kg, orally) for 15 days, followed by treatment with melatonin (10 mg/kg), MPH (10 mg/kg), or their combination for 7 days. Behavioral tests, including the Morris water maze, open field, and Y-maze, were used to assess cognitive function. Hippocampal tissues were analyzed for oxidative stress markers (SOD, MDA), inflammatory cytokines (TNF-α, IL-10), apoptosis-related proteins (Bax, Bcl-2), and histological changes. The combination treatment significantly improved memory and learning, enhanced antioxidant capacity, reduced lipid peroxidation, and suppressed neuroinflammation and apoptosis. Histological examinations revealed increased neuronal density and CA1 hippocampal volume. These findings demonstrate that co-treatment with melatonin and MPH mitigates key pathological features of AD, suggesting a promising combinatorial strategy for targeting oxidative stress, neuroinflammation, and apoptosis in Alzheimer’s disease.
Similar content being viewed by others
Acknowledgements
The authors gratefully acknowledge the financial support of the Neuroscience Institute, Tehran University of Medical Sciences (grant number: 1401-4-233-64199).
Funding
This work was supported by a grant from the Electrophysiology Research Center of Neuroscience Institute of Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Mohammadi, F., Koohi, M.K., Adeli, S. et al. Effects of co-administered melatonin and methylphenidate on cognitive impairment and histopathological alterations in an AlCl₃-induced neurotoxicity model of alzheimer’s disease in BALB/C mice. Sci Rep (2026). https://doi.org/10.1038/s41598-026-43776-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-43776-2
